Cite
Botticelli A, Onesti CE, Zizzari I, et al. The sexist behaviour of immune checkpoint inhibitors in cancer therapy?. Oncotarget. 2017;8(59):99336-99346doi: 10.18632/oncotarget.22242.
Botticelli, A., Onesti, C. E., Zizzari, I., Cerbelli, B., Sciattella, P., Occhipinti, M., Roberto, M., Di Pietro, F., Bonifacino, A., Ghidini, M., Vici, P., Pizzuti, L., Napoletano, C., Strigari, L., D'Amati, G., Mazzuca, F., Nuti, M., & Marchetti, P. (2017). The sexist behaviour of immune checkpoint inhibitors in cancer therapy?. Oncotarget, 8(59), 99336-99346. https://doi.org/10.18632/oncotarget.22242
Botticelli, Andrea, et al. "The sexist behaviour of immune checkpoint inhibitors in cancer therapy?." Oncotarget vol. 8,59 (2017): 99336-99346. doi: https://doi.org/10.18632/oncotarget.22242
Botticelli A, Onesti CE, Zizzari I, Cerbelli B, Sciattella P, Occhipinti M, Roberto M, Di Pietro F, Bonifacino A, Ghidini M, Vici P, Pizzuti L, Napoletano C, Strigari L, D'Amati G, Mazzuca F, Nuti M, Marchetti P. The sexist behaviour of immune checkpoint inhibitors in cancer therapy?. Oncotarget. 2017 Nov 01;8(59):99336-99346. doi: 10.18632/oncotarget.22242. eCollection 2017 Nov 21. PMID: 29245905; PMCID: PMC5725096.
Copy
Download .nbib